The following was meant to be tongue in cheek but actually the subject is too serious and I miss my son too much to make light of this issue.
Did you hear there’s a new syndrome that’s just been confirmed? Yep, LKMS disorder aka ‘Lundbeck Killed My Son’ Disorder. I suppose if I was being fair, it should be called ‘LKMC’ aka ‘Lundbeck killed my Child’ Disorder. There are many of us affected by this virus, although thankfully it isn’t contagious.
It should be noted that LKMC disorder is a global problem, not just restricted to Ireland or the UK. In fact America, New Zealand and China are reporting an ever-increasing rate of suicide. I have previously shown that the unsuspecting Chinese are killing themselves at an alarming rate, most likely due to the relatively new ‘depression’ advertisements, pushed by dubious pharmaceutical companies including Lundbeck, here.
The latest news regarding the DSM-5 is that grief for more than 2 weeks, even after the death of a loved one, can be seen as a symptom of Major Depressive Disorder, here. Considering that Shane is dead almost four years and I can still blubber like a lunatic at the worst possible moments; that surely means I’m decidedly unwell. I wonder if a pill could cure the death of my son? Can they miraculously make him re-appear? Even your toddler’s ‘temper tantrums’ may be diagnosed as an illness under the new and ‘unimproved’ DSM-5 and therefore medicated accordingly.
This week researchers from Duke University reported that antidepressants, including Lundbeck’s Lexapro appears to help prevent a potentially serious stress-related heart condition. You can find the study in ‘The Journal of the American College of Cardiology’ here. I’d list the conflicts of interests but there isn’t enough room on the page. You can access them yourself by clicking the ‘Author Information’. Now you will have to pardon my stupidity here, but surely these researchers know that Lexapro causes heart-attacks and sudden death? The FDA sent out a warning letter to all practitioners advising of the risk of heart problem with Citalopram in August 2011. This was revised in March 2012 to include Escitalopram, which is no surprise as they’re basically the same drug (as found in a Brussel’s Court here).
Lundbeck whose patents (and patience) are running out, have been frantically scrambling around for their next block-buster drug. Vortioxetine aka Brintellix is their latest offering. Data concerning Vortioxetine efficacy was presented at the 2013 American Psychiatric Association Annual Meeting (APA). 4 trial results were shown, 3 for and 1 against. It’s the 1 against that I would be interested in. Was there any deaths? There was certainly a death in one of the Citalopram trials. Are they going to publish all the Vortioxetine trials as GSK are supposed to be doing? Actually no, ignore that, GSK backtracked on that particular promise!
We will have to wait and see whether Vortioxetine will get a ‘licence to kill’ by the FDA and the EMA, and if so, whether it will add to the growing cases of LKMC disorder.